Precigen (PGEN) Treasury Shares (2018 - 2026)
Precigen (PGEN) reported Treasury Shares of $320509.0 for Q1 2026, down 90.48% quarter-over-quarter from $3.4 million in Q4 2025.
Precigen (PGEN) Treasury Shares (2018 - 2026) Analysis & Trends
Precigen (PGEN) has 9 years of Treasury Shares data on file, last reported at $320509.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $320509.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $320509.0 (changed N/A YoY), and the FY2025 annual result was $3.4 million, down 15.91% from the prior year.
- Treasury Shares slipped to $320509.0 in Q1 2026 per PGEN's latest filing, from $3.4 million in the prior quarter.
- Over five years, Treasury Shares peaked at $7.5 million in Q4 2023 and troughed at $320509.0 in Q1 2026.
- A 5-year average of $2.5 million and a median of $979258.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares surged 971.84% in 2023, then slumped 79.34% in 2025.
- A 5-year view of Treasury Shares shows it stood at $697815.0 in 2022, then surged by 971.84% to $7.5 million in 2023, then plunged by 46.47% to $4.0 million in 2024, then fell by 15.91% to $3.4 million in 2025, then sank by 90.48% to $320509.0 in 2026.
- Business Quant data shows PGEN's Treasury Shares at $320509.0 in Q1 2026, $3.4 million in Q4 2025, and $646551.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | 320,509.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 320,509.00 |
| Mar 31, 2026 | 320,509.00 |
| Dec 31, 2025 | 3.37 Mn |
| Dec 31, 2025 | 3.37 Mn |
| Sep 30, 2025 | 646,551.00 |
| Sep 30, 2025 | 646,551.00 |
| Jun 30, 2025 | 773,311.00 |
| Jun 30, 2025 | 773,311.00 |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | 6.15 Mn |
| Mar 31, 2024 | 6.15 Mn |
| Dec 31, 2023 | 7.48 Mn |
| Dec 31, 2023 | 7.48 Mn |
| Dec 31, 2022 | 697,815.00 |
| Dec 31, 2022 | 697,815.00 |
| Sep 30, 2022 | 697,815.00 |
| Sep 30, 2022 | 697,815.00 |